Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Ques ...
Lab-developed tests look likely to be removed from FDA oversight. That has to change, writes Walter G. Johnson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback